Results 111 to 120 of about 61,573 (234)

In‐Vitro Activity of Ceftazidime‐Avibactam and Comparator Agents Against Carbapenem‐Resistant Gram‐Negative Isolates at a Tertiary Care Hospital in Lahore, Pakistan: A Cross‐Sectional Study

open access: yesMicrobiologyOpen, Volume 15, Issue 6, December 2026.
Of 210 consecutive non‐duplicate carbapenem‐resistant Gram‐negative isolates collected at a tertiary care hospital in Lahore, Pakistan (December 2024–May 2025), 200 had a ceftazidime‐avibactam (CAZ–AVI) result; 70.5% were susceptible (141/200; 95% CI 63.7–76.7). Susceptibility varied by sample source (p = 0.008), being highest in blood cultures (81.2%),
Faryal Yunus   +5 more
wiley   +1 more source

Piperacillin–tazobactam tolerability in patients with a labeled penicillin allergy (PIPPEN)

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Background: Piperacillin–tazobactam is a beta-lactam antibiotic with a distinct R1 side chain compared to other penicillins, therefore the risk of cross-reactivity should be theoretically low.
Avneet Purewal   +4 more
doaj   +1 more source

TZP: Pipercillin / Tazobactam 8.12μg/ml and 8 μg.ml.

open access: yes, 2015
TZP: Pipercillin / Tazobactam 8.12μg/ml and 8 μg.ml.
Kristina Crona (567679)   +5 more
core   +1 more source

When the Antibiogram Offers Nothing Else: Ceftriaxone–Sulbactam–Disodium EDTA With Intravenous Colistin in Two Neonates With Metallo‐β‐Lactamase‐Producing Acinetobacter baumannii Meningitis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Two neonates with metallo‐β‐lactamase‐producing Acinetobacter baumannii meningitis, resistant to every tested alternative, received ceftriaxone–sulbactam–disodium EDTA plus intravenous colistin, which, to our knowledge, represents the first reported neonatal use of this combinations. Cultures were sterilized by day 7; both survived with normal
Naini Puri   +5 more
wiley   +1 more source

Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms

open access: yesBiofilm
Objectives: New combinations of β-lactams and β-lactamase inhibitors, such as ceftolozane/tazobactam could be useful to combat biofilm-driven chronic infections by extensively resistant (XDR) Pseudomonas aeruginosa but resistance development by mutations
María Fernández-Billón   +9 more
doaj   +1 more source

Suspected Gluteal Epithelioid Sarcoma Complicated by Secondary Infection and Sciatic Neuropathy: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Secondary infection can coexist with and obscure an underlying soft‐tissue sarcoma. A deep mass that persists or progresses despite drainage and appropriate antibiotics, especially with progressive neurological deficit, warrants image‐guided core biopsy and sarcoma‐center referral before further surgery.
Baraa Nassar   +4 more
wiley   +1 more source

Pharmacokinetics of ceftolozane-tazobactam during prolonged intermittent renal replacement therapy

open access: yes, 2018
Background: Prolonged intermittent renal replacement therapy (PIRRT) eliminates many drugs, and without dosing data, for new antibiotics like ceftolozane/tazobactam, suboptimal concentrations and treatment failure are likely.
Regli, Adrian   +8 more
core   +1 more source

Perioperative Anaphylaxis and Respiratory Failure During AVF Surgery in an End‐Stage Renal Disease Patient

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Perioperative anaphylaxis can cause sudden, catastrophic respiratory and cardiovascular collapse in high‐risk ESRD patients, even during regional anesthesia. Early recognition, prompt epinephrine administration, serum tryptase measurement, vigilant respiratory monitoring, and multidisciplinary preparedness—including ECMO capability—are ...
Madeline Dow   +2 more
wiley   +1 more source

Piperacillin/tazobactam (ZOSYN)

open access: yesInfectious Diseases in Obstetrics and Gynecology, 1996
Culver, Stephanie M., Martens, Mark G.
openaire   +2 more sources

Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination

open access: yes, 2015
Objective: To review the chemistry, pharmacology, microbiology, pharmacokinetics, pharmacodynamics, clinical efficacy, tolerability, dosage, and administration of ceftolozane/tazobactam, a new antipseudomonal cephalosporin combined with a well ...
Chahine, Elias   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy